Avraham Karasik

机构：Tel Aviv University, Sheba Medical Center

发表论文 176 篇 · 总被引 15641 次 · h-index 49

代表论文

• Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs (2018 · Journal of the American College of Cardiology · 被引 472)
• Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD study (2022 · The Lancet Regional Health - Europe · 被引 334)
• Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study (2019 · The Lancet Diabetes & Endocrinology · 被引 316)
• Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study (2020 · The Lancet Diabetes & Endocrinology · 被引 93)
• Prevalence, outcomes and costs of a contemporary, multinational population with heart failure (2023 · Heart · 被引 88)
• Projecting the clinical burden of chronic kidney disease at the patient level (Inside CKD): a microsimulation modelling study (2024 · EClinicalMedicine · 被引 44)